Incruse ellipta 62.5 mcg inh?

Incruse Ellipta 62.5 mcg inhalation is umeclidinium bromide, a long-acting anticholinergic (LAMA) bronchodilator used for maintenance treatment of COPD. It helps open the airways and reduce COPD symptoms and exacerbations. It is not for acute relief of symptoms.

Key points:
- Dose: 1 inhalation (62.5 mcg) once daily.
- Use: Maintenance therapy for COPD. Do not use as a rescue inhaler for sudden breathing problems.
- How it’s used: Use once daily at about the same time each day. The Ellipta device has dose counter and is designed for easy daily use. Follow the exact instructions on your product labeling or patient leaflet. If you’re unsure, ask a pharmacist or clinician for a demonstration.
- Common side effects: dry mouth, sore throat or cough, sinus infection, upper respiratory infections, possible headache. Rarely may cause urinary retention or blurred vision (especially in those with glaucoma or prostate issues).
- Important safety: Avoid if allergic to umeclidinium or any ingredient. Use with caution if you have narrow-angle glaucoma, urinary retention, or severe stomach/intestinal problems. Not a substitute for emergency inhalers. In pregnancy or breastfeeding, consult your clinician.

If you’d like, I can:
- Break down the exact step-by-step usage for the Ellipta device you have,
- List potential drug interactions (e.g., with other anticholinergics),
- Or summarize the full package insert and common/serious side effects.

What would you like to know more about?